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Compartment Syndrome. Intensive Care Med 2013;39:1190-206.EDITORS’ COMMENTARYThomas L. Forbes, MD, and A. Ross Naylor, MBChB, MD, FRCS, Toronto, Ontario, Canada; and Leicester,
United KingdomDuring this era of evidence-based medicine where random-
ized controlled trials (RCTs) are king, we are constantly in search
of level I evidence to guide us. The area of ruptured abdominal
aortic aneurysms (RAAAs) is no exception, but unfortunately,
the attainment of robust level I data has been elusive. The difﬁculty
in performing such a study is one area where our authors agree.
The recent Dutch attempt at an RCT, Amsterdam Acute
Aneurysm (AJAX) trial, failed to show a difference in mortality be-
tween open and endovascular aneurysm repair (EVAR) groups.1
However, before rushing to use this information to disparage
endovascular repair for RAAAs, we need to remember that these
ﬁndings were limited to the small subgroup of 20% of RAAA pa-
tients who were hemodynamically stable and anatomically suitable
for EVAR as determined by a preoperative computed tomography
(CT) scan. Given these inclusion criteria. It is little wonder that no
difference was observed.
The more recent Immediate Management of the Patient with
Ruptured Aneurysm: Open vs Endovascular Repair (IMPROVE)
trial was of a much different design.2 Rather than comparing
EVAR and open repair in a subset of RAAA patients, this prag-
matic trial compared an EVAR approach (CT scan and EVAR, if
anatomically suitable) with an open repair approach (open repair,
with or without CT scan) in all patients with a clinical diagnosis
of an RAAA. Approximately half of the RAAA patients presenting
to study sites were randomized, with a common reason for nonin-
clusion being unavailability of an EVAR team. Although the study
investigators noted a trend toward improved results with EVAR in
women and with the use of local anesthesia, the 30-day mortality
rates were similar between these two approaches by intention-to-
treat analysis.
In the absence of convincing RCTs, proponents of EVAR for
RAAA have relied on single-center and multicenter experiences
comparing open and endovascular repair. As outlined in the
debate, EVAR opponents point to the inherent biases in these re-
ports and the selective reporting of results. Information regarding
the choice between open and endovascular repair in these studies is
often missing or variable. An exception is the only report of com-
plete adoption of EVAR for all RAAA repairs that resulted in a sig-
niﬁcant reduction in perioperative mortality compared with the
previous era of EVAR when possible.3Of course, all of these reports, RCTs or otherwise, offer
limited information regarding the entire RAAA cohort of patients
because they include only those who undergo an attempted repair.
This is not an unimportant issue, because a recent population-
based study reported that 20% of RAAA patients in the United
States and 41% in England did not receive any repair.4 Lower mor-
tality after the intervention was associated with larger hospital case
loads, admission on weekdays, and increased use of EVAR.
Our authors would surely agree that no repair is a poor choice
in most patients compared with any type of intervention, whether
it be open repair or EVAR. It is with these patients who are turned
down for repair where the greatest potential beneﬁt exists, some of
whom are not transferred when open repair is the only option and
they are deemed too high risk. The wider adoption of EVAR for
RAAA has the potential to create further high-volume centers
with consistently available EVAR and open surgical expertise
resulting in transfer of more patients and reduction in these turn
down rates, regardless of the eventual method of repair. For this
reason, wider adoption of EVAR for RAAA should be encouraged.REFERENCES
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